Particle.news

Download on the App Store

Europe’s Drug Market Shifts to Domestic ‘Bath Salts’ and Potent Opioids

Laboratories in Poland are supplanting imports with potent cathinones alongside rising nitazene opioids that drive overdose spikes.

Image
Image

Overview

  • The European Union Drugs Agency monitored over 1,000 new psychoactive substances and found a sharp rise in synthetic cathinone and opioid use across Europe in 2024.
  • Authorities dismantled 53 synthetic cathinone production sites in 2023—40 of which were in Poland—marking a shift from Asian imports to local manufacturing.
  • Nitazene opioids, some stronger than fentanyl, have been detected in fake prescription pills and linked to recent overdose clusters in at least 12 countries.
  • Cocaine remains the leading illicit stimulant with 4.6 million European users in 2024 and record seizures of 419 tonnes reported for the seventh consecutive year.
  • Drug-induced deaths climbed to 7,500 in 2023, predominantly from opioids, prompting experts to call for expanded drug checking and targeted research.